2022 Annual Meeting | C1 - Non-motor Parkinson’s Disease Symptoms
Program Materials Program Evaluations
06:30 AM - 07:00 AM PDT | Speaker |
Walk-in Slides
|
07:00 AM - 07:30 AM PDT | Speaker |
Prodromal Non-motor Symptoms in Parkinson's Disease
Shyamal Mehta, MD, PhD, FAAN |
07:30 AM - 08:10 AM PDT | Speaker |
The Spectrum of Autonomic Dysfunction in PD
Yi-Han Lin, MD |
08:10 AM - 08:50 AM PDT | Speaker |
Neuropsychiatric Manifestations in PD
Holly A. Shill, MD, FAAN |
08:50 AM - 09:00 AM PDT | Q&A |
Questions and Answers
Holly A. Shill, MD, FAAN, Shyamal Mehta, MD, PhD, FAAN |
Holly A. Shill, MD, FAAN | Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage Biogen. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for KeifeRx. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis Precision Medicine. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fasikl Inc. Dr. Shill has received personal compensation in the range of $0-$499 for serving as a Consultant for Boston Scientific. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe Pharma America. |
Shyamal Mehta, MD, PhD, FAAN | Dr. Mehta has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Adamas Pharma. Dr. Mehta has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Dr. Mehta has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CNS Ratings. |
Yi-Han Lin, MD | The institution of Dr. Lin has received research support from Neurocrine BioScience. The institution of Dr. Lin has received research support from UniQure. The institution of Dr. Lin has received research support from CHDI. The institution of Dr. Lin has received research support from Prilenia Therapeutics. The institution of Dr. Lin has received research support from Vaccinex Inc. The institution of Dr. Lin has received research support from Boston Scientific. |